
Gastric Balloon Systems Market Report 2026
Global Outlook – By Product Type (Single Intragastric Balloons, Dual Intragastric Balloons, Swallowable Gastric Balloon Capsules, Adjustable Gastric Balloons), By Filling Material (Saline Filled Balloons, Gas Filled Balloons), By Application (Obesity Management, Pre Bariatric Surgery Weight Reduction, Weight Loss For Overweight Patients, Other Weight Management Applications), By End User (Hospitals, Bariatric Clinics, Ambulatory Surgical Centers, Specialty Gastroenterology Clinics, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Gastric Balloon Systems Market Report 2026 Market Overview
• Gastric Balloon Systems Market Report 2026 market size has reached to $14.55 billion in 2025 • Expected to grow to $24.93 billion in 2030 at a compound annual growth rate (CAGR) of 11.4% • Growth Driver: The Rising Prevalence Of Obesity Fueling The Growth Of The Market Through Increasing Demand For Non-Surgical Weight Management • Market Trend: Focusing Securing Regulatory Approvals For Innovative Procedure-Free Gastric Balloon Technologies • North America was the largest region in 2025 and Middle East is the fastest growing region.What Is Covered Under Gastric Balloon Systems Market?
Gastric balloon systems refer to temporary, non-surgical weight management devices consisting of a soft, expandable silicone elastomer balloon that is delivered into the stomach endoscopically or via a swallowable capsule and subsequently filled with sterile saline or gas. By occupying a significant volume within the gastric cavity, the balloon induces early satiety and delays gastric emptying, helping patients adhere to calorie-restricted diets. The main product types of gastric balloon systems include single intragastric balloons, dual intragastric balloons, swallowable gastric balloon capsules, and adjustable gastric balloons. Single intragastric balloons refer to minimally invasive weight management devices placed inside the stomach to occupy space, promote early satiety, and support weight loss without permanent anatomical changes. These products are available as saline filled balloons and gas filled balloons. The various applications involved are obesity management, pre bariatric surgery weight reduction, weight loss for overweight patients and other weight management applications, and they are used by several end users such as hospitals, bariatric clinics, ambulatory surgical centers, specialty gastroenterology clinics, and others.
What Is The Gastric Balloon Systems Market Size and Share 2026?
The gastric balloon systems market size has grown rapidly in recent years. It will grow from $14.55 billion in 2025 to $16.18 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing prevalence of obesity and obesity-related health conditions, rising awareness about non-surgical weight management options, growing demand for minimally invasive bariatric procedures, increasing adoption of endoscopic weight loss interventions, rising healthcare focus on obesity prevention and metabolic health improvement.What Is The Gastric Balloon Systems Market Growth Forecast?
The gastric balloon systems market size is expected to see rapid growth in the next few years. It will grow to $24.93 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing adoption of swallowable gastric balloon capsules, growing demand for personalized obesity treatment approaches, rising expansion of bariatric specialty clinics, increasing development of advanced balloon materials and designs, growing acceptance of temporary weight loss devices among overweight patients. Major trends in the forecast period include increasing adoption of minimally invasive gastric balloon procedures for obesity management, growing preference for swallowable gastric balloon systems to reduce procedural complexity, rising demand for temporary and reversible weight loss interventions, increasing development of adjustable gastric balloon technologies for personalized weight management, growing focus on improving patient comfort and reducing complications associated with gastric balloons.
Global Gastric Balloon Systems Market Segmentation
1) By Product Type: Single Intragastric Balloons, Dual Intragastric Balloons, Swallowable Gastric Balloon Capsules, Adjustable Gastric Balloons 2) By Filling Material: Saline Filled Balloons, Gas Filled Balloons 3) By Application: Obesity Management, Pre Bariatric Surgery Weight Reduction, Weight Loss For Overweight Patients, Other Weight Management Applications 4) By End User: Hospitals, Bariatric Clinics, Ambulatory Surgical Centers, Specialty Gastroenterology Clinics, Other End Users Subsegments: 1) By Single Intragastric Balloons: Saline Filled Single Balloons, Gas Filled Single Balloons, Endoscopically Placed Single Balloons, Endoscopically Removed Single Balloons 2) By Dual Intragastric Balloons: Dual Saline Filled Balloon Systems, Dual Independent Chamber Balloon Systems, Endoscopically Placed Dual Balloons, Adjustable Dual Balloon Systems 3) By Swallowable Gastric Balloon Capsules: Procedure Free Swallowable Balloons, Self Inflating Capsule Balloons, Gas Filled Capsule Balloons, X Ray Guided Capsule Balloons 4) By Adjustable Gastric Balloons: Volume Adjustable Saline Balloons, Endoscopically Adjustable Balloons, Post Placement Adjustable Balloon Systems, Long Term Adjustable Balloon SystemsWhat Is The Driver Of The Gastric Balloon Systems Market?
The rising prevalence of obesity is expected to propel the growth of the gastric balloon systems market going forward. Obesity refers to a chronic medical condition characterized by excessive body fat accumulation that increases the risk of metabolic disorders, cardiovascular diseases, and other serious health complications. The prevalence of obesity is increasing as sedentary lifestyles, high-calorie diets, urbanization, and limited physical activity continue to affect populations across both developed and developing countries. Gastric balloon systems support obesity management by providing a temporary, minimally invasive weight-loss solution that helps patients achieve early satiety, reduce calorie intake, and lose weight before or instead of bariatric surgery. For instance, in May 2025, according to Gov.UK, a UK-based government agency, from 2023 to 2024, an estimated 64.5% of adults aged 18 years and older in England were overweight or living with obesity, up from 64.0% in 2022 to 2023. Therefore, the rising prevalence of obesity is driving the growth of the gastric balloon systems industry.Key Players In The Global Gastric Balloon Systems Market
Major companies operating in the gastric balloon systems market report are Allurion Technologies Inc., Beijing ZKSK Technology Co. Ltd., Boston Scientific Corporation, CSC MEDSIL, Districlass Médical SA., Endalis, Hélioscopie S.A.S., LEXEL S.R.L., Medicone, ReShape Lifesciences Inc., Silimed Indústria de Implantes Ltda., Spatz FGIA Inc., Suzhou Shenyun Medical Equipment Co. Ltd.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.

This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Global Gastric Balloon Systems Market Trends and Insights
Major companies operating in the gastric balloon systems market are focusing on obtaining regulatory approvals for innovative, minimally invasive, procedure-free gastric balloon technologies to expand treatment accessibility and strengthen their market presence. A procedure-free gastric balloon technology is a non-surgical weight loss device that is swallowed as a capsule and placed in the stomach without the need for endoscopy, anesthesia, or surgery, where it occupies space to promote early satiety and reduce food intake for temporary obesity management. For instance, in February 2026, Allurion Technologies, a US-based medical device company, received U.S. FDA approval for its Allurion Gastric Balloon System, including the swallowable Allurion Smart Capsule, for short-term weight loss in adults with obesity. The approval enables a procedure-free treatment that does not require surgery, endoscopy, or anesthesia, expanding access to minimally invasive obesity management.What Are Latest Mergers And Acquisitions In The Gastric Balloon Systems Market?
In April 2023, Boston Scientific Corporation, a US-based provider of medical devices for interventional cardiology and peripheral interventions, acquired Apollo Endosurgery Inc. for $636 million. With this acquisition, Boston Scientific aims to strengthen its endoscopy portfolio by expanding its minimally invasive gastrointestinal and endobariatric solutions, enhancing its capabilities in obesity management, accelerating innovation in endoluminal procedures, and broadening its global market presence. Apollo Endosurgery Inc. is a US-based manufacturing company that manufactures gastric balloon systems.
Regional Outlook
North America was the largest region in the gastric balloon systems market in 2025. Middle East is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Gastric Balloon Systems Market?
The gastric balloon systems market consists of sales of intragastric balloon devices, balloon delivery systems, balloon retrieval systems, inflation equipment, guidewires, catheters, and related procedural accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.

This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
What Key Data and Analysis Are Included in the Gastric Balloon Systems Market Report 2026?
The gastric balloon systems market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastric balloon systems industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Gastric Balloon Systems Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $16.18 billion |
| Revenue Forecast In 2030 | $24.93 billion |
| Growth Rate | CAGR of 11.4% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Filling Material, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Allurion Technologies Inc., Beijing ZKSK Technology Co. Ltd., Boston Scientific Corporation, CSC MEDSIL, Districlass Médical SA., Endalis, Hélioscopie S.A.S., LEXEL S.R.L., Medicone, ReShape Lifesciences Inc., Silimed Indústria de Implantes Ltda., Spatz FGIA Inc., Suzhou Shenyun Medical Equipment Co. Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
